|
US5266488A
(en)
|
1988-04-06 |
1993-11-30 |
The Regents Of The University Of California |
Troponin T gene promoter and derivatives thereof
|
|
AU1082901A
(en)
|
1999-10-18 |
2001-04-30 |
National Jewish Medical And Research Center |
Method for modulation of cell phenotype
|
|
AU2002254529A1
(en)
|
2001-04-04 |
2002-10-21 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of |
Nucleic acids for transgene expression
|
|
ES2344253T3
(es)
*
|
2001-10-11 |
2010-08-23 |
MERCK SHARP & DOHME CORP. |
Vacuna contra el virus de la hepatitis c.
|
|
US20030221207A1
(en)
|
2002-02-13 |
2003-11-27 |
Pharmacia Corporation, Global Patent Department |
Cardiac-specific 11beta hydroxysteroid dehydrogenase type 2 transgenic mice
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
CA2579519A1
(en)
|
2004-09-09 |
2006-03-16 |
The General Hospital Corporation |
Modulating phosphatase activity in cardiac cells
|
|
EP1828390B1
(en)
|
2004-12-15 |
2012-06-13 |
The University Of North Carolina At Chapel Hill |
Chimeric vectors
|
|
WO2008153543A2
(en)
|
2006-10-27 |
2008-12-18 |
Stowers Institute For Medical Research |
Fluorescent mouse model
|
|
US20100261169A1
(en)
|
2007-01-29 |
2010-10-14 |
Shira Wallach |
Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
|
|
DK2623605T3
(en)
|
2007-04-09 |
2019-03-25 |
Univ Florida |
RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
US20090133138A1
(en)
*
|
2007-11-15 |
2009-05-21 |
Huai-Jen Tsai |
New gene fragment, novel transgenic zebrafish and methods for producing transgenic zebrafish
|
|
CA2705862C
(en)
|
2007-11-16 |
2018-03-27 |
San Diego State University Research Foundation |
Compositions and method for manipulating pim-1 activity in circulatory system cells
|
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
US20110158947A1
(en)
|
2008-07-11 |
2011-06-30 |
Aleksandar Jovanovic |
Sulfonylurea receptor and means for treating ischaemia
|
|
CA2736877A1
(en)
|
2008-09-12 |
2010-03-18 |
Scarab Genomics, Llc |
Clean genome bactofection
|
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
|
CN103608455B
(zh)
|
2011-01-07 |
2019-01-15 |
应用遗传科技公司 |
用于治疗色盲和其它疾病的启动子、表达盒、载体、药盒和方法
|
|
DE102011018586A1
(de)
|
2011-04-26 |
2012-10-31 |
Oliver Müller |
Vektorsystem zur spezifischen Genexpression im Herzmuskel
|
|
CA2837322C
(en)
|
2011-05-26 |
2023-03-21 |
University Of Washington |
Cell and gene based methods to improve cardiac function
|
|
WO2013009825A1
(en)
|
2011-07-11 |
2013-01-17 |
Cellular Dynamics International, Inc. |
Methods for cell reprogramming and genome engineering
|
|
KR101966208B1
(ko)
|
2011-07-21 |
2019-04-09 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
환자로부터 유도 만능 줄기 세포들로부터의 심근 세포 및 그 사용 방법
|
|
US8933048B2
(en)
|
2011-09-21 |
2015-01-13 |
Case Western Reserve University |
Methods of treating cardiomyopathy
|
|
US20130136729A1
(en)
|
2011-11-11 |
2013-05-30 |
University of Virginia Patent Foundation, d/b/a University of Virginia Licensing & Ventures Group |
Compositions and methods for targeting and treating diseases and injuries using adeno-associated virus vectors
|
|
US9051387B2
(en)
|
2012-06-22 |
2015-06-09 |
Wisconsin Alumni Research Foundation |
Inhibition of MyBP-C binding to myosin as a treatment for heart failure
|
|
EP2885008B1
(en)
*
|
2012-08-15 |
2018-11-07 |
University Of Virginia Patent Foundation |
Compositions and methods for treating peripheral arterial disease
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
AU2014321211A1
(en)
|
2013-09-23 |
2016-05-05 |
President And Fellows Of Harvard College |
Allele-specific RNA silencing for the treatment of hypertrophic cardiomyopathy
|
|
EP3572513B1
(en)
|
2013-12-09 |
2025-09-24 |
Baylor College of Medicine |
Hippo and dystrophin complex signaling in cardiomyocyte renewal
|
|
DE102014000857A1
(de)
|
2014-01-27 |
2015-07-30 |
Martin-Luther-Universität Halle-Wittenberg |
Hybridom-Zelllinie (My-C-cC0C2-235-3H8) und deren Verwendung zur Herstellung eines monoklonalen Antikörpers gegen das humane, herzspezifische Myosin Binding Protein C (C-protein, MYBPC3, cMyBP-C oder My-C)
|
|
WO2015127128A2
(en)
|
2014-02-19 |
2015-08-27 |
University Of Massachusetts |
Recombinant aavs having useful transcytosis properties
|
|
WO2015124546A1
(en)
|
2014-02-19 |
2015-08-27 |
Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii- Cnic |
Aav vectors for the treatment of ischemic and non-ischemic heart disease
|
|
WO2015153357A1
(en)
|
2014-03-29 |
2015-10-08 |
Beat Biotherapeutics Corp. |
Compositions and methods for improving cardiac function
|
|
US9611304B2
(en)
|
2014-05-29 |
2017-04-04 |
The University Of British Columbia |
TNNT1 mini-promoters
|
|
US10370432B2
(en)
|
2014-10-03 |
2019-08-06 |
University Of Massachusetts |
Heterologous targeting peptide grafted AAVS
|
|
WO2016065001A1
(en)
|
2014-10-21 |
2016-04-28 |
University Of Massachusetts |
Recombinant aav variants and uses thereof
|
|
WO2016115543A2
(en)
*
|
2015-01-16 |
2016-07-21 |
University Of Washington |
Novel micro-dystrophins and related methods of use
|
|
JP6836999B2
(ja)
|
2015-03-24 |
2021-03-03 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ |
アデノ随伴ウイルス変異体及びその使用方法
|
|
CN115094062A
(zh)
|
2015-04-16 |
2022-09-23 |
埃默里大学 |
用于肝脏中蛋白质表达的重组启动子和载体及其用途
|
|
WO2017091807A1
(en)
|
2015-11-25 |
2017-06-01 |
University Of Miami |
Peptide inhibitors for calcineurin
|
|
AU2016366549B2
(en)
|
2015-12-11 |
2022-11-10 |
California Institute Of Technology |
Targeting peptides for directing adeno-associated viruses (AAVs)
|
|
US11124546B2
(en)
|
2015-12-14 |
2021-09-21 |
The University Of North Carolina At Chapel Hill |
Modified capsid proteins for enhanced delivery of parvovirus vectors
|
|
SG10201912935WA
(en)
*
|
2015-12-15 |
2020-02-27 |
Genzyme Corp |
Adeno-associated viral vectors for treating mucolipidosis type ii
|
|
WO2017192750A1
(en)
|
2016-05-04 |
2017-11-09 |
Oregon Health & Science University |
Recombinant adeno-associated viral vectors
|
|
JP7100629B2
(ja)
|
2016-06-09 |
2022-07-13 |
セントレ・ナショナル・デ・ラ・レシェルシェ・サイエンティフィーク |
化学修飾されたカプシドを有するｒａａｖ
|
|
WO2018050783A1
(en)
|
2016-09-14 |
2018-03-22 |
Ruprecht-Karls-Universität |
Adeno-associated virus (aav) based regulatory system
|
|
US20200024576A1
(en)
|
2016-10-05 |
2020-01-23 |
The Regents Of The University Of California |
Cardiac tissue models and methods of use thereof
|
|
CN108384806A
(zh)
|
2016-10-17 |
2018-08-10 |
新疆医科大学第附属医院 |
hPDGF-BB与hFGF2双基因重组病毒载体及其应用
|
|
US20190275035A1
(en)
|
2016-11-04 |
2019-09-12 |
Ruprecht-Karls-Universität Heidelberg |
Wnt antagonists and their use in methods for treating myocardial infarction
|
|
JOP20190166A1
(ar)
|
2017-01-05 |
2019-07-02 |
Univ Texas |
استراتيجية مثلى من أجل تعديلات تخطي إكسون باستخدام crispr/cas9 مع متواليات توجيه ثلاثي
|
|
EP3583220A4
(en)
|
2017-02-15 |
2021-07-07 |
The University of North Carolina at Chapel Hill |
PROCEDURES AND COMPOSITIONS FOR GENERAL TRANSFER IN THE VASCULAR SYSTEM
|
|
US10550405B2
(en)
|
2017-03-15 |
2020-02-04 |
The University Of North Carolina At Chapel Hill |
Rational polyploid adeno-associated virus vectors and methods of making and using the same
|
|
WO2018222503A1
(en)
|
2017-05-31 |
2018-12-06 |
The Regents Of The University Of California |
Adeno-associated virus with variant capsid and methods of use thereof
|
|
US10907153B2
(en)
|
2017-07-06 |
2021-02-02 |
Michael S. KAPILOFF |
Treatment of heart disease by inhibtion of the action of muscle A-kinase anchoring protein (mAKAP)
|
|
US11512327B2
(en)
|
2017-08-03 |
2022-11-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of AAV
|
|
DK3684423T5
(da)
|
2017-09-20 |
2024-08-26 |
4D Molecular Therapeutics Inc |
Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf
|
|
WO2019060619A1
(en)
|
2017-09-20 |
2019-03-28 |
The Regents Of The University Of California |
STRATEGY OF GENE THERAPY FOR RESTORING ELECTRICAL AND CARDIAC FUNCTION AND CARDIAC STRUCTURE IN ARYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
|
|
US12404522B2
(en)
|
2018-01-19 |
2025-09-02 |
Agency For Science, Technology And Research |
Disrupting the LINC complex for treating laminopathy
|
|
GB2571704A
(en)
|
2018-02-22 |
2019-09-11 |
Georg August Univ Gottingen Stiftung Offentlichen Rechts Univer Sitatsmedzin Goettingen |
Prevention or treatment of cardiac arrhytmia and sudden cardiac death
|
|
EP3768327A4
(en)
*
|
2018-03-23 |
2022-04-13 |
The Trustees of Columbia University in the City of New York |
GENE EDIT FOR AUTOSOMAL DOMINANT DISEASES
|
|
JP2021530218A
(ja)
|
2018-07-11 |
2021-11-11 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. |
血液脳関門を超える薬剤の送達のための方法および組成物
|
|
US11242368B2
(en)
|
2018-09-21 |
2022-02-08 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Methods and compositions for rapidly replacing cardiac myosin binding protein-C in sarcomeres
|
|
BR112021009913A2
(pt)
|
2018-12-05 |
2021-08-17 |
Abeona Therapeutics, Inc. |
vetor viral adeno-associado recombinante para inserção gênica
|
|
CN109810981A
(zh)
|
2019-02-19 |
2019-05-28 |
上海交通大学医学院附属第九人民医院 |
多聚核苷酸及其在心血管疾病诊断和治疗中的应用
|
|
CN113727992A
(zh)
|
2019-03-21 |
2021-11-30 |
斯特里迪比奥公司 |
重组腺相关病毒载体
|
|
JP7659271B2
(ja)
|
2019-03-28 |
2025-04-09 |
ザ ジェネラル ホスピタル コーポレイション |
導入遺伝子発現のための操作されたアデノ随伴（ａａｖ）ベクター
|
|
US20200405824A1
(en)
|
2019-06-26 |
2020-12-31 |
University Of Washington |
Use of ribonucleotide reductase alone or in combination with micro-dystrophin to treat duchenne muscular dystrophy striated muscle disease
|
|
CA3149444A1
(en)
|
2019-08-27 |
2021-03-04 |
Johannes HOLZMEISTER |
Drug perfusion into an unarrested beating heart
|
|
TWI897882B
(zh)
|
2019-09-20 |
2025-09-21 |
英商Ｕｃｌ商業有限責任公司 |
右心室心律失常性心肌病之基因療法組合物及治療
|
|
US20230047424A1
(en)
|
2019-12-09 |
2023-02-16 |
Ucl Business Ltd |
Gene therapy composition and treatment for myh7-linked cardiomyopathy
|
|
EP4081643A1
(en)
|
2019-12-24 |
2022-11-02 |
Asklepios Biopharmaceutical, Inc. |
Regulatory nucleic acid sequences
|
|
FI4103214T3
(fi)
|
2020-02-13 |
2026-07-03 |
Tenaya Therapeutics Inc |
Geeniterapian vektorit sydänsairauden hoitoon
|
|
AU2021259422A1
(en)
|
2020-04-20 |
2022-12-08 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
|
CN115803042A
(zh)
|
2020-07-08 |
2023-03-14 |
儿童医学中心公司 |
Mybpc3多肽及其用途
|
|
IL300187A
(en)
|
2020-08-05 |
2023-03-01 |
Spacecraft Seven Llc |
Gene therapy CSRP3 (protein 3 rich in cysteine and glycine)
|
|
WO2022032226A1
(en)
|
2020-08-07 |
2022-02-10 |
Spacecraft Seven, Llc |
Plakophilin-2 (pkp2) gene therapy using aav vector
|
|
EP4267594A1
(en)
|
2020-12-23 |
2023-11-01 |
Boehringer Ingelheim International GmbH |
Viral capsid proteins with specificity to heart tissue cells
|
|
BR112023016797A2
(pt)
|
2021-02-22 |
2024-01-16 |
Dinaqor Ag |
Perfusão loco-regional de um rim
|
|
WO2022175545A1
(en)
|
2021-02-22 |
2022-08-25 |
Dinaqor Ag |
Loco-regional perfusion of a liver
|
|
US20240148948A1
(en)
|
2021-02-22 |
2024-05-09 |
Dinaqor Ag |
Loco-regional perfusion of an unarrested beating heart
|